Implications for HIV Vaccine Development

What did this research study show? Not only is PI virus neutralization achievable, but broad vaccine protection may not require an unlimited number of HIV serotypes.

In its current form, an inactivated whole-cell FC vaccine is not practical for clinical development, especially those that require tumor cell lines in their generation.

What are 2 major concerns? Safety and the difficulty of immunogen production

Gaining greater understanding of the nature of the fusion-related structures that are the most probable targets of the relevant antibodies might permit their expression as recombinant proteins. These experiments performed by LaCasse et al. should provide further evidence that an effective neutralizing antibody component would be a worthwhile, and ultimately achievable, component of an effective HIV-1 vaccine.

___________________________________________________________

The Model of a Fusion-Competent Immunogen by LaCasse et al. ______________________________________________________

This finishes the literature exploration of this research article!

Click here to go back to Main Menu